Polyethylene glycol-conjugated human adrenomedullin as a possible treatment for vascular dementia
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Japan Science and Technology Agency (ST262010WV)
This publication has 24 references indexed in Scilit:
- Prediction of Alzheimer’s Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic PeptideThe Journal of Clinical Psychiatry, 2010
- A new amyloid β variant favoring oligomerization in Alzheimer's‐type dementiaAnnals of Neurology, 2008
- Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesisExperimental Neurology, 2006
- Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formationFEBS Letters, 2005
- Adrenomedullin Administration Immediately After Myocardial Infarction Ameliorates Progression of Heart Failure in RatsCirculation, 2004
- Adrenomedullin Reduces Ischemic Brain Injury after Transient Middle Cerebral Artery Occlusion in RatsActa Neurochirurgica, 2001
- Intravenous Infusion of Adrenomedullin and Increase in Regional Cerebral Blood Flow and Prevention of Ischemic Brain Injury after Middle Cerebral Artery Occlusion in RatsJournal of Cerebral Blood Flow & Metabolism, 1997
- Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage.Proceedings of the National Academy of Sciences, 1995
- Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasmaFEBS Letters, 1994
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993